{"chunk_id": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)__chunk_20", "source": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)", "text": "e physician \nshould carefully consider both the potential risks of taking an SSRI, along \nwith the established benefits of treating depression with an \nantidepressant. This decision can only be made on a case by case basis.  \nFDA/CDER/OND/ODEIV/DPMH 22 \nRisk Summary \nThere are no adequate and well-controlled studies of [TRADENAME] in \npregnant women.  The limited available information on [TRADENAME] \nuse during pregnancy is not sufficient to inform a drug-associated risk of \nmajor birth defects"}